Companies: 10,795·Total market cap: $144.5T
Charming Medical Limited Class A Ordinary Shares

Charming Medical Limited Class A Ordinary Shares

MCTANASDAQHealthcare
$29.36
+$1.86(+6.75%)
Market Cap$445550190
P/E Ratio
52W High$31.7
52W Low$4.3

Charming Medical Limited Class A Ordinary Shares (MCTA) Revenue

Annual & quarterly revenue history · segment & region breakdown

MCTA · revenue · updated Jun 8, 2026

Core revenue metrics

Charming Medical Limited Class A Ordinary Shares trailing twelve-month (TTM) revenue is $0.00B, an increase of 3.43% year-over-year from $0.01B in FY2025.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+3.43%
vs FY2025 $0.01B
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
49 employees
FY2025
$0.01B
FY2024
$0.01B
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Charming Medical Limited Class A Ordinary Shares SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20252023 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-03-31$0.01B+$0.00B+3.43%
2024-03-31$0.01B+$0.00B+70.37%
2023-03-31$0.00B
MCTA revenue by year · MCTA revenue history · MCTA annual revenue data

Compare revenue vs peers

Medical - Care Facilities

Compare MCTA revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Charming Medical Limited Class A Ordinary Shares receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Charming Medical Limited Class A Ordinary Shares reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Charming Medical Limited Class A Ordinary Shares's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

MCTA revenue · 4 questions

MCTA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 3.43% year-over-year from $0.01B in FY2025.

MCTA revenueMCTA annual revenuewhat is MCTA revenueMCTA TTM revenue

Source: FMP · Charming Medical Limited Class A Ordinary Shares SEC filings · GAAP · Charming Medical Limited Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026